From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Weekly Wrap 12 June

Jessica Amir
June 12, 2020

Morning Bell 12 June

Jessica Amir
June 12, 2020

Morning Bell 11 June

Bell Direct
June 11, 2020

Morning Bell 10 June

Jessica Amir
June 10, 2020

Morning Bell 9 June

Jessica Amir
June 9, 2020

Weekly Wrap 5 June

Jessica Amir
June 5, 2020

Morning Bell 5 June

Jessica Amir
June 5, 2020

Morning Bell 4 June

Jessica Amir
June 4, 2020

Morning Bell 3 June

Jessica Amir
June 3, 2020

Morning Bell 2 June

Jessica Amir
June 2, 2020